LONG-TERM INVIVO CARCINOGENICITY STUDY OF PHENYTOIN (5,5-DIPHENYLHYDANTOIN) IN F344 RATS

被引:11
作者
JANG, JJ
TAKAHASHI, M
FURUKAWA, F
TOYODA, K
HASEGAWA, R
SATO, H
HAYASHI, Y
机构
[1] NATL INST HYG SCI,DEPT PATHOL,KAMIYOGA 1-18-1,SETAGAYA KU,TOKYO 158,JAPAN
[2] KOREA CANC CTR HOSP,DEPT PATHOL,DOBONG KU,SEOUL 13002,SOUTH KOREA
关键词
D O I
10.1016/0278-6915(87)90103-7
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
引用
收藏
页码:697 / 702
页数:6
相关论文
共 31 条
[21]  
PERAINO C, 1975, CANCER RES, V35, P2884
[22]  
Peto R, 1980, IARC Monogr Eval Carcinog Risk Chem Hum Suppl, P311
[23]   MUTAGENICITY OF ANTIEPILEPTIC DRUGS .2. PHENYTOIN, PRIMIDONE AND PHENOBARBITAL [J].
RIEDEL, L ;
OBE, G .
MUTATION RESEARCH, 1984, 138 (01) :71-74
[24]  
SOLLEVELD HA, 1984, J NATL CANCER I, V72, P929
[25]   TERATOGENIC ACTIVITY OF ANTIEPILEPTIC DRUGS PHENOBARBITAL, PHENYTOIN, AND PRIMIDONE IN MICE [J].
SULLIVAN, FM ;
MCELHATTON, PR .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1975, 34 (02) :271-282
[26]  
TOYODA K, 1986, IYAKUHIN KENKYU, V17, P1219
[27]  
WHITE SJ, 1979, LANCET, V2, P458
[28]  
1984, AUG AD HOC PAN CHEM
[29]  
1982, MONOGRAPHS EVALUAT S, V4, P215
[30]  
1976, CARCINOGENESIS TECHN, V1